Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$108,982,067
-$8,401,646 QoQ
Shares Held
476,466
-13.4% QoQ
Ownership
0.726%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 99.84699852665247.ToString("F0")%
None 0.15300147334752112.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Mar 31, 2026CallValue
$94,122,395
CallShares
411,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. ASND ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in ASND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,122,395 | 411,500 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $108,982,067 | 476,466 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $117,383,713 | 550,477 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $111,917,304 | 562,936 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $101,500,708 | 588,069 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $105,975,914 | 679,943 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $96,721,572 | 702,561 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $99,995,444 | 669,717 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $90,101,083 | 660,662 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,339,444 | 55,166 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,847,944 | 62,310 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,672,335 | 60,576 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,124,245 | 68,619 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,793,417 | 54,033 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $6,611,629 | 54,136 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,624,262 | 54,467 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,663,338 | 50,165 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,080,303 | 51,809 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,535,063 | 48,577 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,158,695 | 51,187 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,910,452 | 52,531 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,191,008 | 48,037 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,700,617 | 70,156 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $11,239,124 | 72,830 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $10,909,547 | 73,763 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,299,582 | 73,702 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||